Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Karla A. Lee"'
Autor:
Niccolò Rossi, Karla A. Lee, Maria V. Bermudez, Alessia Visconti, Andrew Maltez Thomas, Laura A. Bolte, Johannes R. Björk, Laura Kist de Ruijter, Julia Newton-Bishop, Mark Harland, Heather M. Shaw, Mark Harries, Joseph Sacco, Ruth Board, Paul Lorigan, Elisabeth G.E. de Vries, Nicola Segata, Leonie Taams, Sophie Papa, Tim D. Spector, Paul Nathan, Rinse K. Weersma, Geke A.P. Hospers, Rudolf S.N. Fehrmann, Veronique Bataille, Mario Falchi
Publikováno v:
EBioMedicine, Vol 83, Iss , Pp 104235- (2022)
Summary: Background: Inflammation can modulate tumour growth and progression, and influence clinical response to treatment. We investigated the potential of circulating inflammatory proteins for response stratification of immune checkpoint inhibitor
Externí odkaz:
https://doaj.org/article/2653e1f206bf4483825a0683e7b29ab7
Autor:
Marc F. Österdahl, Karla A. Lee, Mary Ni Lochlainn, Stuart Wilson, Sam Douthwaite, Rachel Horsfall, Alyce Sheedy, Simon D. Goldenberg, Christopher J. Stanley, Tim D. Spector, Claire J. Steves
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-8 (2020)
Abstract Background A cost effective and efficient diagnostic tool for COVID-19 as near to the point of care (PoC) as possible would be a game changer in the current pandemic. We tested reverse transcription loop mediated isothermal amplification (RT
Externí odkaz:
https://doaj.org/article/3560d14154544216b8bb1e295d7fb5e5
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Pp 108-112 (2020)
Externí odkaz:
https://doaj.org/article/e731976e1f474a189502524620eaf680
Autor:
Karla A. Lee, Paul Nathan
Publikováno v:
Acta Dermato-Venereologica, Vol 100, Iss 11, p adv00141 (2020)
This decade has brought significantly improved outcomes for patients with advanced melanoma with immunotherapies and targeted treatments offering utility in a variety of settings. In 2020, we can hope for durable long-term responses, and complete rem
Externí odkaz:
https://doaj.org/article/ded58a3edaeb419d8de1127dfa0a2e3b
Autor:
Alessia Visconti, Niccolò Rossi, Helena Deriš, Karla A Lee, Maja Hanić, Irena Trbojević-Akmačić, Andrew M. Thomas, Laura A. Bolte, Johannes R. Björk, Jahlisa S. Hooiveld-Noeken, Ruth Board, Mark Harland, Julia Newton-Bishop, Mark Harries, Joseph J. Sacco, Paul Lorigan, Heather M. Shaw, Elisabeth G.E. de Vries, Rudolf S.N. Fehrmann, Rinse K. Weersma, Tim D. Spector, Paul Nathan, Geke A. P. Hospers, Peter Sasieni, Veronique Bataille, Gordan Lauc, Mario Falchi
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of melanoma and other cancers. However, no reliable biomarker of survival or response has entered the clinic to identify those patients with melanoma who are mo
Externí odkaz:
https://doaj.org/article/50b511b7f9af46e6993f096da9d33865
Autor:
Niamh Cunningham, Scott Shepherd, Kabir Mohammed, Karla A. Lee, Mark Allen, Stephen Johnston, Emma Kipps, Sophie McGrath, Jillian Noble, Marina Parton, Alistair Ring, Nicholas C. Turner, Alicia F. C. Okines
Publikováno v:
Breast Cancer Research and Treatment. 195:333-340
To describe the tolerability and efficacy of neratinib as a monotherapy and in combination with capecitabine in advanced HER2-positive breast cancer in a real-world setting.Patients who received neratinib for advanced HER2-positive at the Royal Marsd
Publikováno v:
British Journal of Cancer
The gut microbiome (GM) has been implicated in a vast number of human pathologies and has become a focus of oncology research over the past 5 years. The normal gut microbiota imparts specific function in host nutrient metabolism, xenobiotic and drug
Autor:
Amy L. Roberts, Kerrin S. Small, Maxim B. Freidin, Finbarr C. Martin, Claire J. Steves, Carly Welch, Marc Modat, M. Ni Lochlainn, Carole H. Sudre, Rose S. Penfold, Massimo Mangino, J. S. El-Sayed Moustafa, M. B. Zazzara, Alessia Visconti, Benjamin J. Murray, Hannah Dooley, Sebastian Ourselin, Ruth C. E. Bowyer, Karla A. Lee, Jonathan Wolf
Publikováno v:
Age and Ageing
Introduction COVID-19 exhibits a more severe disease course in older adults with frailty. Awareness of atypical presentations is critical to facilitate early disease identification. This study aimed to assess how frailty affects presenting symptoms o
Autor:
Laura A. Bolte, Karla A. Lee, Johannes R. Björk, Emily R. Leeming, Marjo J. E. Campmans-Kuijpers, Jacco J. de Haan, Arnau Vich Vila, Andrew Maltez-Thomas, Nicola Segata, Ruth Board, Mark Harries, Paul Lorigan, Elisabeth G. E. de Vries, Paul Nathan, Rudolf Fehrmann, Véronique Bataille, Tim D. Spector, Geke A. P. Hospers, Rinse K. Weersma
Publikováno v:
JAMA Oncology. 9:705
ImportanceImmune checkpoint blockade (ICB) has improved the survival of patients with advanced melanoma. Durable responses are observed for 40% to 60% of patients, depending on treatment regimens. However, there is still large variability in the resp
Autor:
Karla A. Lee, Andrew Maltez Thomas, Laura A. Bolte, Johannes R. Björk, Laura Kist de Ruijter, Federica Armanini, Francesco Asnicar, Aitor Blanco-Miguez, Ruth Board, Neus Calbet-Llopart, Lisa Derosa, Nathalie Dhomen, Kelly Brooks, Mark Harland, Mark Harries, Emily R. Leeming, Paul Lorigan, Paolo Manghi, Richard Marais, Julia Newton-Bishop, Luigi Nezi, Federica Pinto, Miriam Potrony, Susana Puig, Patricio Serra-Bellver, Heather M. Shaw, Sabrina Tamburini, Sara Valpione, Amrita Vijay, Levi Waldron, Laurence Zitvogel, Moreno Zolfo, Elisabeth G. E. de Vries, Paul Nathan, Rudolf S. N. Fehrmann, Véronique Bataille, Geke A. P. Hospers, Tim D. Spector, Rinse K. Weersma, Nicola Segata
Publikováno v:
Nature Medicine
Lee, K A, Thomas, A M, Bolte, L A, Björk, J R, de Ruijter, L K, Armanini, F, Asnicar, F, Blanco-Miguez, A, Board, R, Calbet-Llopart, N, Derosa, L, Dhomen, N, Brooks, K, Harland, M, Harries, M, Leeming, E R, Lorigan, P, Manghi, P, Marais, R, Newton-Bishop, J, Nezi, L, Pinto, F, Potrony, M, Puig, S, Serra-Bellver, P, Shaw, H M, Tamburini, S, Valpione, S, Vijay, A, Waldron, L, Zitvogel, L, Zolfo, M, de Vries, E G E, Nathan, P, Fehrmann, R S N, Bataille, V, Hospers, G A P, Spector, T D, Weersma, R K & Segata, N 2022, ' Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma ', Nature Medicine, vol. 28, no. 3, pp. 535-544 . https://doi.org/10.1038/s41591-022-01695-5
Nature Medicine, 28. Nature Publishing Group
Lee, K A, Thomas, A M, Bolte, L A, Björk, J R, de Ruijter, L K, Armanini, F, Asnicar, F, Blanco-Miguez, A, Board, R, Calbet-Llopart, N, Derosa, L, Dhomen, N, Brooks, K, Harland, M, Harries, M, Leeming, E R, Lorigan, P, Manghi, P, Marais, R, Newton-Bishop, J, Nezi, L, Pinto, F, Potrony, M, Puig, S, Serra-Bellver, P, Shaw, H M, Tamburini, S, Valpione, S, Vijay, A, Waldron, L, Zitvogel, L, Zolfo, M, de Vries, E G E, Nathan, P, Fehrmann, R S N, Bataille, V, Hospers, G A P, Spector, T D, Weersma, R K & Segata, N 2022, ' Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma ', Nature Medicine, vol. 28, no. 3, pp. 535-544 . https://doi.org/10.1038/s41591-022-01695-5
Nature Medicine, 28. Nature Publishing Group
The composition of the gut microbiome has been associated with clinical responses to immune checkpoint inhibitor (ICI) treatment, but there is limited consensus on the specific microbiome characteristics linked to the clinical benefits of ICIs. We pe